Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

BIOCHEMICAL DIAGNOSTICS INC

United States·US-MF-000025179

Last updated May 24, 2026

What BIOCHEMICAL DIAGNOSTICS INC makes

The company produces in vitro diagnostic (IVD) controls and reagents for detecting drugs of abuse in urine samples, including multi-panel tests for various substances. It also manufactures controls for ethanol (ETOH) testing and kits for measuring 17-hydroxycorticoid levels via spectrophotometry, alongside urine analyte controls and a human chorionic gonadotropin beta-core fragment test. Additional offerings include pregnancy screening tests and a device for monitoring vital signs.

These products fall under Class I and In Vitro Diagnostic (IVD) General device classifications, with regulatory listings in the EU’s EUDAMED database, the FDA’s 510(k) premarket notification process, and the FDA’s Unique Device Identifier (UDI) system. The manufacturer operates from the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Biochemical Diagnostics Inc manufacture?

Biochemical Diagnostics Inc specializes in in vitro diagnostic (IVD) products, primarily controls and reagents for detecting drugs of abuse in urine samples. Their portfolio includes multi-panel tests for various substances, ethanol (ETOH) controls, and kits for measuring 17-hydroxycorticoid levels using spectrophotometry. They also produce controls for urine analyte testing, a human chorionic gonadotropin beta-core fragment test, pregnancy screening devices, and a vital sign monitoring device. These products are designed for laboratory and point-of-care use.

Where is Biochemical Diagnostics Inc based, and what does that mean for regulatory oversight?

Biochemical Diagnostics Inc is based in the United States. Since the company operates in the U.S., its devices are subject to FDA regulations, including premarket notification (510(k)) requirements for Class I devices and compliance with the FDA’s Unique Device Identifier (UDI) system. The company’s products are also listed in the EU’s EUDAMED database, indicating they may be marketed or used in the European Union under applicable IVD regulations, though this does not imply EU approval.

How are the devices manufactured by Biochemical Diagnostics Inc classified under regulatory frameworks?

The devices produced by Biochemical Diagnostics Inc fall under Class I classification and In Vitro Diagnostic (IVD) General categories. Class I devices are typically considered low-risk, often requiring general controls like labeling and manufacturing practices, while IVD General classifications apply to diagnostic tests that do not pose significant health risks. This classification helps determine the regulatory pathway, such as FDA’s 510(k) process for Class I devices, ensuring compliance without stringent pre-market approval.

Which regulatory registries list the devices made by Biochemical Diagnostics Inc?

The devices manufactured by Biochemical Diagnostics Inc are listed in three key regulatory registries: EUDAMED, the European database for medical devices; the FDA’s 510(k) premarket notification database, which tracks Class I device submissions in the U.S.; and the FDA’s Unique Device Identifier (UDI) system, ensuring traceability and compliance tracking. These listings reflect the company’s adherence to regulatory requirements in both the U.S. and EU markets, though they do not confirm individual device approvals.

Why do some of the company’s devices appear under multiple names (e.g., Detectabuse vs. DETECTABUSE)?

The variations in naming conventions (e.g., *Detectabuse* vs. *DETECTABUSE*) likely reflect differences in branding, case sensitivity in labeling, or regional marketing preferences. Some devices may also appear under multiple names due to updates, rebranding, or variations in product lines (e.g., controls vs. kits). These discrepancies do not affect regulatory classification or compliance but may appear in databases or documentation depending on how the manufacturer registers or lists the device. Always refer to the official labeling or regulatory submissions for precise identification.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
180, Heartland Blvd, Edgewood, United States
LinkedIn
—
Facebook
—
Phone
6315959200
PRRC Contact
Amy Walsh
EUDAMED SRN
US-MF-000025179
FDA FEI Number
—
DUNS Number
028007698

Catalogue (484)

Page 4 of 10
DeviceModel / ReferenceRegistriesClassStatus
Detectabuse 18003208
FDA UDI
Class IActive
Detectabuse 702037
FDA UDI
Class IActive
Steroid-Skreen 35062106
FDA UDI
Class IUnknown
Detectabuse Custom QC14
FDA UDI
Class IUnknown
Detectabuse 18003078
FDA UDI
Class IActive
Detectabuse 18008335
FDA UDI
Class IActive
Detectabuse 18002836
FDA UDI
Class IActive
Detectabuse 18008256
FDA UDI
Class IActive
Detectabuse 18030393
FDA UDI
Class IActive
Dpi 18002998
FDA UDI
Class IActive
Detectabuse 18001422
FDA UDI
Class IActive
Vma-Skreen 35071903
FDA UDI
Class IUnknown
Alere 88002
FDA UDI
Class IActive
Detectabuse MULTITOX-NC-25
FDA UDI
Class IActive
Salivabuse 18200177
FDA UDI
Class IActive
Detectabuse 18030392
FDA UDI
Class IActive
Steroid-Skreen 35062211
FDA UDI
Class IUnknown
Detectabuse 18002145
FDA UDI
Class IActive
Detectabuse 18008511
FDA UDI
Class IActive
Detectabuse 18008472
FDA UDI
Class IActive
iScreen 88006
FDA UDI
Class IActive
Steroid-Skreen 35062408
FDA UDI
Class IUnknown
Detectabuse Custom QC05
FDA UDI
Class IUnknown
Detectabuse 18008466
FDA UDI
Class IActive
Detectabuse 18008333
FDA UDI
Class IActive
Pregnancy-Skreen Custom QC30
FDA UDI
Class IUnknown
Alere 88001
FDA UDI
Class IActive
Premier PQ-22-01
FDA UDI
Class IActive
Detectabuse 18008622
FDA UDI
Class IActive
Detectabuse 19481320
FDA UDI
Class IActive
Detectabuse 18002929
FDA UDI
Class IActive
Detectabuse 18008051
FDA UDI
Class IActive
Vma-Skreen 35071202
FDA UDI
Class IUnknown
Adulter-Skreen 20300002
FDA UDI
Class IActive
Vma-Skreen 35071601
FDA UDI
Class IUnknown
Detectabuse 18007568
FDA UDI
Class IActive
Steroid-Skreen 35066242
FDA UDI
Class IUnknown
Detectabuse 18030394
FDA UDI
Class IActive
Vma-Skreen 35071504
FDA UDI
Class IUnknown
Steroid-Skreen 35061924
FDA UDI
Class IActive
Steroid-Skreen 35062807
FDA UDI
Class IActive
Detectabuse 18030390
FDA UDI
Class IActive
Detectabuse 18008249
FDA UDI
Class IActive
Detectabuse 18003226
FDA UDI
Class IActive
Detectabuse 18003079
FDA UDI
Class IActive
Vma-Skreen 35071156
FDA UDI
Class IUnknown
Detectabuse Custom QC20
FDA UDI
Class IActive
Detectabuse 14100325
FDA UDI
Class IUnknown
Salivabuse 18100185
FDA UDI
Class IActive
Detectabuse 18003009
FDA UDI
Class IActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (1)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Biochemical Diagnostics Inc. has one recall record initiated on 2015-09-14, which is marked as terminated. The recall pertains to CONSULT diagnostics hCG Controls, where discrepancies were noted between the storage temperatures listed on the kit labels and those on the individual vial labels and the package insert.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Sep 14, 2015Z-0328-2016—terminated

CONSULT diagnostics hCG Controls have discrepant storage temperatures listed on the kit labels when compared with the individual vial labels and the package insert.